Skip to main content

Jessica Hagen

By Jessica Hagen | 03:58 pm | April 30, 2025
Americans with a prescription will have access to Novo Nordisk's obesity drug Wegovy through the Hims & Hers platform for $599 monthly.
By Jessica Hagen | 12:42 pm | April 29, 2025
Juan Lavista Ferres, CVP and chief data scientist at Microsoft's AI for Good Lab, and Meghana Kshirsagar, senior research scientist, discuss their research on protein symmetry.
By Jessica Hagen | 09:00 am | April 28, 2025
The integration allows UpToDate Enterprise customers and their patients direct access to a library of multilingual patient education materials within Epic’s EHR and MyChart.
By Jessica Hagen | 11:43 am | April 25, 2025
The digital mental health tool maker will retire its teen-focused app as of June 30.
By Jessica Hagen | 03:37 pm | April 24, 2025
The health insurer unintentionally exposed the personal data of 4.7 million people to Google through a misconfigured analytics tool used between 2021 and 2024.
By Jessica Hagen | 12:15 pm | April 24, 2025
The New York-based healthcare benefits navigation platform raised its Series B round despite not actively seeking funding.
By Jessica Hagen | 05:41 pm | April 23, 2025
The food-as-medicine platform will grow its workforce and offerings as rising food prices from new Trump tariffs underscore the need for accessible, nutrition-based care.
By Jessica Hagen | 01:58 pm | April 23, 2025
The San Francisco-based musculoskeletal care platform will be included in Cigna’s offerings for self-insured employers.
By Jessica Hagen | 02:11 pm | April 22, 2025
The company claims the acquisition will strengthen its AI-enabled platform, improve care gap management and promote collaboration to advance value-based care.
By Jessica Hagen | 12:26 pm | April 22, 2025
The company's patch uses intradermal electrochemical sensors to monitor glucose levels and provide metabolic insights to individuals with type 2 diabetes not on insulin.